OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.520
0.00 (0.00%)
At close: Oct 15, 2025, 4:00 PM EDT
1.500
-0.020 (-1.32%)
After-hours: Oct 15, 2025, 7:50 PM EDT
OPKO Health Revenue
OPKO Health had revenue of $156.81M in the quarter ending June 30, 2025, a decrease of -13.93%. This brings the company's revenue in the last twelve months to $664.03M, down -7.31% year-over-year. In the year 2024, OPKO Health had annual revenue of $713.14M, down -17.41%.
Revenue (ttm)
$664.03M
Revenue Growth
-7.31%
P/S Ratio
1.59
Revenue / Employee
$221,565
Employees
2,997
Market Cap
1.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 713.14M | -150.35M | -17.41% |
| Dec 31, 2023 | 863.50M | -140.70M | -14.01% |
| Dec 31, 2022 | 1.00B | -770.52M | -43.42% |
| Dec 31, 2021 | 1.77B | 339.31M | 23.64% |
| Dec 31, 2020 | 1.44B | 533.48M | 59.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
OPK News
- 4 weeks ago - Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses - PRNewsWire
- 2 months ago - OPKO Health, Inc. (OPK) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results - GlobeNewsWire
- 3 months ago - NextPlat Issues Interim CEO Update Shareholder Letter - PRNewsWire
- 4 months ago - OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium - GlobeNewsWire
- 5 months ago - OPKO Health to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 6 months ago - OPKO Health, Inc. (OPK) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program - GlobeNewsWire